Investment Firm Ups Stake in ABI; Encourages Board to Seek 'Strategic Alternatives' | GenomeWeb
NEW YORK (GenomeWeb News) – Investment firm SAC Capital Advisors disclosed in a US Securities and Exchange Commission filing today that it has increased its stake in Applied Biosystems to 5.1 percent and that it has encouraged ABI’s board of directors to explore strategic alternatives for the firm including a possible sale.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.